CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Horizontal mitochondrial transfer and the tug-of-war between cancer cells and immune cells.
Horizontal mitochondrial transfer and the tug-of-war between cancer cells and immune cells.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
水平线粒体转移(HMT)是细胞生物学的一个新兴领域。自被发现以来,由于线粒体在为肿瘤细胞增殖提供能量中的关键作用,HMT 在癌症背景下得到了广泛研究。然而,HMT 在癌症中的作用远不止是一种简单的细胞器获取机制。事实上,近期多项研究已证明 HMT 可从癌细胞转移至免疫细胞,反之亦然,并对抗肿瘤免疫应答产生深远影响,且可能影响免疫治疗疗效。在这篇观点文章中,我们提出 HMT 应作为癌症与免疫细胞之间功能拉锯战的另一种可调控机制而受到关注,它进一步增加了肿瘤微环境的复杂性,并可能塑造这两类细胞之间竞争的结果。
Horizontal mitochondrial transfer (HMT) is an emerging field of cell biology. Since its discovery, HMT has been extensively studied in the context of cancer due to the essential role of mitochondria in fueling the proliferation of tumor cells. The role of HMT in cancer, however, reaches far beyond a simple mechanism of organelle acquisition.
Indeed, several recent studies have demonstrated HMT from cancer to immune cells and vice versa, with a profound impact on antitumor immune responses and potentially on immunotherapy efficacy. In this opinion article, we propose that HMT should receive attention as another modulatable mechanism of the functional tug-of-war between cancer and immune cells, further contributing to the complexity of the tumor microenvironment and likely sculpting the outcome of competition between the two teams of cells.
MEMBER ACCOUNT
登录成功会直接打开下一页。